QA: Karuna Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001771917_2023_Karuna_Therapeutics_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001771917, Karuna Therapeutics Inc.

  xvar xval
0 AssetsCurrent 1,154,769,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,201,000
3 remainder_Assets 5,364,000
4 LiabilitiesCurrent 33,946,000
5 LiabilitiesNoncurrent 3,150,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 76,066,000
9 ResearchAndDevelopmentExpense 224,247,000
10 remainder_Expenses 1,418,000
11 remainder_Revenues 10,637,000
12 remainder_NetIncome 14,758,000
13 remainder_ComprehensiveNetIncome -2,793,000
  yvar yval
0 Assets 1,163,334,000
1 Liabilities 37,096,000
2 Expenses 301,731,000
3 Revenues 10,637,000
4 StockholdersEquity 1,126,238,000
5 NetIncome -276,336,000
6 ComprehensiveNetIncome -277,732,500
7 BaseVar 765,174,500
8 EconomicCapitalRatio 2.76

Edgar->Model Mapping

Feature Distribution

Change over Time